Dashboard
Analysis
Charting
Screener
Resources
Settings
NasdaqGS-NFLX
Mar '15
Dec '16
Sep '18
Jun '20
Mar '22
Dec '23
Sep '25
Trailing Valuation
Stock Price
119.9
133.9
93.3
89.1
70.9
67.5
Total Shares Outstanding
4,237.3
4,249.3
4,256.8
4,277.6
4,274.6
4,291.6
Market Cap
508,021.2
569,031.6
396,962.4
381,268.5
303,183.2
289,634.6
Total Enterprise Value (TEV)
513,159.8
575,094.3
403,608.3
387,267.5
309,940.6
296,958.8
Buyback Yield
1.4%
1.2%
1.7%
2.4%
2.8%
Debt Paydown Yield
0.4%
0.3%
0.2%
-0.4%
0.1%
Shareholder Yield
1.8%
1.5%
1.9%
1.1%
2.5%
2.9%
P/S
11.7
13.6
9.9
9.8
8.1
8
P/Gross Profit
24.4
28.1
21.1
21.2
17.8
18.2
P/E
50.1
57.1
44.1
44.9
40.1
42.2
Earnings Yield
2%
2.3%
2.2%
P/OCF
53.1
62.7
50
51.8
40.5
P/FCF
56.7
66.9
53.3
55.1
42.6
42.5
FCF Yield
P/B
19.6
22.8
16.5
15.4
13.3
13.1
EV/Sales
11.8
13.8
10
8.2
EV/Gross Profit
24.6
28.4
21.4
21.6
18.7
EV/EBITDA
39.6
45.6
35.2
36
31.1
33
EV/EBIT
40.6
46.7
36.3
37.2
32.1
34.3
EV/OCF
53.6
63.4
50.8
52.6
41.4
41.5
EV/FCF
57.2
67.7
54.2
55.9
43.5
Margins
Gross Profit Margin
46.4%
51.9%
50.1%
43.7%
47.9%
45.9%
Operating Margin
28.2%
34.1%
31.7%
22.2%
29.6%
27.2%
EBITDA Margin
29%
34.8%
32.5%
23%
30.4%
28.1%
Net Profit Margin
22.1%
27.4%
18.2%
24.1%
22.5%
Effective Tax Rate
18.1%
13.9%
10.1%
12.4%
12.6%
14.6%
Pre-Tax Profit Margin
27%
32.8%
30.5%
20.8%
27.5%
26.3%
Free Cash Flow Margin
23.1%
20.5%
25.2%
13.5%
22.3%
12.7%
OCF / Sales
24.5%
21.9%
26.5%
15%
23.6%
OCF / Net Income
110.9%
77.5%
96.5%
82.2%
98.2%
60.1%
FCF / OCF
94.2%
93.6%
95.4%
89.7%
94.5%
93.9%
FCF / Net Income
104.5%
72.5%
92.1%
73.8%
92.8%
56.5%
FCF / EBITDA
79.8%
58.8%
77.6%
58.6%
73.4%
45.2%
Capital Efficiency
Return on Invested Capital
5.6%
6.9%
6.5%
4.3%
5.5%
4.8%
Return on Assets
5%
6.4%
6%
3.9%
4.5%
Return on Equity
10.5%
13.3%
8.2%
9.6%
Return on Total Capital
12.3%
15.8%
11.4%
Return on Capital Employed
7.5%
9.1%
7%
Return on Tangible Assets
12%
16.4%
15.5%
9.8%
12.5%
12.1%
Payables Turnover
8.6
8.7
7
8.5
Days Payables Outstanding
42.4
52.1
41.9
42.8
Cash Conversion Cycle
-42.5
-42.2
-42.4
-52.1
-41.9
-42.8
Asset Turnover
0.2
Fixed Asset Turnover
6.8
6.7
6.6
6.4
CapEx to OCF
0.1
0
CapEx to Revenue
CapEx to Depreciation
1.9
1.6
2
1
Financial Health
Total Debt
14,463
14,453.2
15,016.9
15,582.8
15,981.3
13,980.1
Net Debt
5,138.6
6,062.7
6,645.9
5,999.1
6,757.4
7,324.2
Current Ratio
1.3
1.2
1.1
0.9
Quick Ratio
0.7
Cash Ratio
Debt Ratio
0.3
Assets to Equity
2.1
2.2
2.3
Cash Flow to Debt Ratio
Long-term Debt to Assets
Intangibles to Total Assets
0.6
Net Current Asset Value
-16,017.9
-16,154.7
-16,361.9
-15,786.4
-17,432
-17,370.6
Debt / Equity
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
1.5
2.6
2.7
EBIT / Interest Expense
18.5
20.7
15.7
15.5
EBITDA / Interest Expense
19
18.6
12.2
16.2
16
(EBITDA - Capex) / Interest Expense
18.1
20.3
17.9
11.4
Per Share
Revenue per Share
2.5
2.4
Basic EPS
0.4
0.5
Diluted EPS
Book Value per Share
6
5.7
5.5
5.2
5
Tangible Book Value per Share
-1.5
-1.6
-1.8
-2.2
Cash per Share
Operating Cash Flow per Share
Free Cash Flow per Share
CapEx per Share
Weighted Avg. Shares Outstanding
4,244.6
4,252.1
4,272.7
4,277.2
4,282.4
4,300.7
Weighted Avg. Shares Outstanding Diluted
4,340.4
4,348.8
4,369.6
4,377.9
4,379
4,397.4
Common Size
R&D to Revenue
7.4%
7.8%
7.6%
SG&A to Revenue
10.8%
10.4%
14%
11.2%
Stock-based Comp to Revenue
0.7%
0.6%
